BVS
Bioventus·NASDAQ
--
--(--)
--
--(--)
BVS fundamentals
Bioventus (BVS) Revenue Breakdown: Q3 2025 Business & Regional Performance
Bioventus (BVS) reported total revenue of 138.65M USD in Q3 2025, with its core business segment Pain Treatments contributing 48.45%. Regionally, United States remained the largest market, accounting for 88.94% of total revenue. Explore Bioventus's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Bioventus (BVS) reported total revenue of 138.65M USD in Q3 2025, with its core business segment Pain Treatments contributing 48.45%. Regionally, United States remained the largest market, accounting for 88.94% of total revenue. Explore Bioventus's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Bioventus’s earnings call?What is Bioventus's gross profit margin?What is Bioventus's latest dividend and current dividend yield?What were the key takeaways from Bioventus's earnings call?Did Bioventus beat or miss consensus estimates last quarter?What factors drove the changes in Bioventus's revenue and profit?What guidance did Bioventus's management provide for the next earnings period?What does Bioventus do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
